Back to Journals » OncoTargets and Therapy

OncoTargets and Therapy


ISSN: 1178-6930

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

Journal Impact Factor: 3.337 (5 year impact 3.044)

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

 

 

 

 

Indexed online:

 

  • PubMed and PubMed Central (Onco Targets Ther) 
  • Science Citation Index Expanded (also known as SciSearch®)
  • Journal Citation Reports/Science Edition
  • Biological Abstracts
  • BIOSIS Previews
  • Embase, from 2009 (Correct as at December 8, 2016)
  • Scopus, from 2009 (Correct as at December 8, 2016)
  • Directory of Open Access Journals (DOAJ)
  • OAIster: The Open Access Initiative

Latest articles:

- 5 records -

Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide

Wang H, Shi H, He X, Liao A

OncoTargets and Therapy 2021, 14:2789-2795

Published Date: 21 April 2021

A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy

Hayat H, Hayat H, Dwan BF, Gudi M, Bishop JO, Wang P

OncoTargets and Therapy 2021, 14:2761-2772

Published Date: 20 April 2021

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis

Zhang J, Du C, Zhang L, Wang Y, Zhang Y, Li J

OncoTargets and Therapy 2021, 14:2747-2759

Published Date: 20 April 2021

 

Read more articles